- Report
- October 2023
- 175 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- October 2023
- 190 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- October 2023
- 190 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- October 2023
- 182 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- October 2023
- 177 Pages
Global
From €4701EUR$4,900USD£4,065GBP
- Report
- November 2023
- 182 Pages
Global
From €4701EUR$4,900USD£4,065GBP
From €6237EUR$6,500USD£5,393GBP
- Report
- February 2024
- 150 Pages
Global
From €4558EUR$4,750USD£3,941GBP
- Report
- February 2024
- 143 Pages
Global
From €4558EUR$4,750USD£3,941GBP
- Report
- February 2024
- 100 Pages
Global
From €4558EUR$4,750USD£3,941GBP
- Report
- August 2023
- 90 Pages
Global
From €4558EUR$4,750USD£3,941GBP
- Report
- August 2023
- 110 Pages
Global
From €4558EUR$4,750USD£3,941GBP
- Clinical Trials
- April 2024
- 200 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Drug Pipelines
- April 2024
- 220 Pages
Global
From €2878EUR$3,000USD£2,489GBP
- Drug Pipelines
- April 2024
- 100 Pages
Global
From €2878EUR$3,000USD£2,489GBP
- Clinical Trials
- April 2024
- 210 Pages
Global
From €2399EUR$2,500USD£2,074GBP
- Clinical Trials
- April 2024
- 120 Pages
Global
From €1919EUR$2,000USD£1,659GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1439EUR$1,500USD£1,245GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1439EUR$1,500USD£1,245GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1439EUR$1,500USD£1,245GBP
The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more